(Il Sole 24 Ore Radiocor) - Milano, 22 apr - The Luxembourg-based life sciences company Eurofins Scientific said it generated revenue of 1.789 billion euros in the first quarter of 2025, up by 1.3% compared to the year earlier as a lift to its top line from organic growth of 2.6% and acquisitions more than offset currency headwinds.

Organic growth in Europe in the quarter stood at 1.7%, or 1.6% excluding a public working days adjustment. Organic growth in North America amounted to 2.1% on both an adjusted and unadjusted basis, while in the rest of the world Eurofins posted organic growth of 9.1%, or 8.6% excluding the public working days adjustment.

Eurofins said its profitability and margins "continued to progress significantly" in the quarter "despite temporarily subdued revenue growth." The company said its strategic growth investments continued, with the closure of 10 business combinations and asset deals with 2025 revenue of 55 million euros, as well as the initiation of five start-up laboratories and three blood collection points (BCPs).

Eurofins reiterated its objectives for fiscal year 2026, the.

mid-term and fiscal year 2027.

(RADIOCOR) 22-04-26 09:13:20 (0196) 5 NNNN